Double administration of self-complementary AAV9NDUFS4 prevents Leigh disease in Ndufs4-/- mice

Corra et al. show that double administration of a self-complementary-adeno-associated viral 9 vector expressing human NDUFS4, via intra-vascular and intra-cerebroventricular injections on P1, prevents the onset of Leigh-like disease in Ndufs4(-/-) mice. The intervention extends healthy lifespan by several months compared to untreated mice. Leigh disease, or subacute necrotizing encephalomyelopathy, a genetically heterogeneous condition consistently characterized by defective mitochondrial bioenergetics, is the most common oxidative-phosphorylation related disease in infancy. Both neurological signs and pathological lesions of Leigh disease are mimicked by the ablation of the mouse mitochondrial respiratory chain subunit Ndufs4(-/-), which is part of, and crucial for, normal Complex I activity and assembly, particularly in the brains of both children and mice. We previously conveyed the human NDUFS4 gene to the mouse brain using either single-stranded adeno-associated viral 9 recombinant vectors or the PHP.B adeno-associated viral vector. Both these approaches significantly prolonged the lifespan of the Ndufs4(-/-) mouse model but the extension of the survival was limited to a few weeks by the former approach, whereas the latter was applicable to a limited number of mouse strains, but not to primates. Here, we exploited the recent development of new, self-complementary adeno-associated viral 9 vectors, in which the transcription rate of the recombinant gene is markedly increased compared with the single-stranded adeno-associated viral 9 and can be applied to all mammals, including humans. Either single intra-vascular or double intra-vascular and intra-cerebro-ventricular injections were performed at post-natal Day 1. The first strategy ubiquitously conveyed the human NDUFS4 gene product in Ndufs4(-/-) mice, doubling the lifespan from 45 to approximate to 100 days after birth, when the mice developed rapidly progressive neurological failure. However, the double, contemporary intra-vascular and intra-cerebroventricular administration of self-complementary-adeno-associated viral NDUFS4 prolonged healthy lifespan up to 9 months of age. These mice were well and active at euthanization, at 6, 7, 8 and 9 months of age, to investigate the brain and other organs post-mortem. Robust expression of hNDUFS4 was detected in different cerebral areas preserving normal morphology and restoring Complex I activity and assembly. Our results warrant further investigation on the translatability of self-complementary-adeno-associated viral 9 NDUFS4-based therapy in the prodromal phase of the disease in mice and eventually humans.

Automated summary

Corra et al. have shown that double administration of a self-complementary adeno-associated viral 9 vector expressing human NDUFS4 can prevent the onset of Leigh-like disease in Ndufs4(-/-) mice and extend their healthy lifespan. This intervention has potential for further investigation in the prodromal phase of the disease in mice and eventually humans.